Showing results (1-10 of 277) with videos related to
Sort By:
Pageof 28
Biology and Medicine (Aligarh)|May 10, 2016
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving ParadigmHernando Lopez-Bertoni, Yunqing Li, John LaterraTranslational Oncology|March 15, 2021
Opinion: miRNAs - The new wave of molecular cancer therapeuticsHernando Lopez-Bertoni, John LaterraMolecular & Cellular Oncology|June 17, 2016
The cancer stem cell phenotype: You can't win until you learn how to lose itHernando Lopez-Bertoni, John LaterraFrontiers in Oncology|October 10, 2022
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunitiesAmanda L Johnson, John Laterra, Hernando Lopez-BertoniBiorxiv : the Preprint Server for Biology|January 20, 2025
TGFBR2 High mesenchymal glioma stem cells phenocopy regulatory T cells to suppress CD4+ and CD8+ T cell functionAmanda L Johnson, Harmon S Khela, Jack Korleski, et al.Cells|April 25, 2025
Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 CellsAmanda L Johnson, Harmon S Khela, Jack Korleski, et al.Cancer Research|February 3, 2012
Cancer stem cells: distinct entities or dynamically regulated phenotypes?Yunqing Li, John LaterraGenes & Diseases|July 5, 2022
Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growthDaqian Zhan, Fatih Yalcin, Ding Ma, et al.Molecular Cancer Research : MCR|August 5, 2021
Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of SenescenceDaqian Zhan, Ding Ma, Shuang Wei, et al.Epigenetics|August 1, 2017
TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agentsJonathan B Coulter, Hernando Lopez-Bertoni, Katherine J Kuhns, et al.Pageof 28